You asked me why I liked the BioHealth deal- I answered
You asked how CGB planned to export/import- I answered
Now your concern has moved to the business model?
This is actually a better conversation.
I'm sure that extensive cost analysis has been undertaken by CGB before committing to any partnership that is not financially beneficial to the business or shareholders.
I actually spoke about risk managment to the business model & owning as many of the components as possible not long ago.
As a business matures..Hopefully producing revenue it will look to de-risk the business model as it can afford to..At this early stage CGB are sourcing business partners to help grow their business.
As for the companies 1-5 years master plan..Perhaps when Sholom gets a chance to breath some of your immediate concerns will be addressed in this business plan.
Like licenses for example.
For now it's about being resourceful with the companies limited budget.
I'm sure Sholom is awake to possible risks.
Your concern for the business model is probably the one of the better questions in recent times.
Also MOU's are legally binding if they satisfy all 6 elements of a contract.
Regards, Dan.
CGB Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held